Company Analysis

West Pharmaceutical Services, Inc. (WST)

NYSE: WST · Surgical & Medical Instruments & Apparatus · Exton, PA · filing with the SEC since 1994
Grade5.7
◀ Past 6.3● Present 6.3▶ Future 4.3

Filings

245 filings since 2017 beside 439 insider forms · Large accelerated filer · read from EDGAR on Nov 13, 2026
Due nextLarge accelerated filer
10-K Annual report for the fiscal year ending Dec 31, 2026Large accelerated filers have 60 days after the fiscal year ends. by Mar 1, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Large accelerated filers have 40 days after the quarter ends; quarter ends are taken to the month end. by May 10, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 29 days after the quarter ended. The proxy statement was last filed Mar 12, 2026.

Filings a yearinsider forms included
6471646966625362
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 11 times in the last 36 months, the newest Jun 1, 2026.Serious cyber incident (8-K item 1.05): 2 times in the last 36 months, the newest May 20, 2026.
Insider forms 439

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 5, 2026 SCHEDULE 13G/A Large holder update, amended
Oct 29, 2026 10-Q Quarterly report Sep 30, 2026
Oct 29, 2026 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Oct 26, 2026 8-K items 1.01, 1.02, 2.03, 9.01 Major agreement signed; Major agreement ended; New debt or obligation taken on · Current report
Aug 6, 2026 SCHEDULE 13G Large holder notice
Jul 23, 2026 10-Q Quarterly report Jun 30, 2026
Jul 23, 2026 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Jul 14, 2026 8-K items 1.01, 9.01 Major agreement signed · Current report
Jun 1, 2026 8-K items 5.02, 7.01, 9.01 Officer or director change; Investor disclosure (Regulation FD) · Current report May 31, 2026
May 20, 2026 8-K/A items 1.05, 9.01 Serious cyber incident · Current report, amended May 7, 2026
May 13, 2026 SD Conflict minerals report
May 11, 2026 8-K items 1.05, 7.01, 9.01 Serious cyber incident; Investor disclosure (Regulation FD) · Current report May 7, 2026
May 5, 2026 8-K items 5.07, 9.01 Shareholder vote · Current report May 4, 2026
Apr 30, 2026 SCHEDULE 13G Large holder notice
Apr 29, 2026 SCHEDULE 13G Large holder notice
Apr 23, 2026 10-Q Quarterly report Mar 31, 2026
Apr 23, 2026 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Mar 27, 2026 SCHEDULE 13G/A Large holder update, amended
Mar 12, 2026 DEFA14A Extra proxy material
Mar 12, 2026 DEF 14A Proxy statement May 4, 2026
Mar 9, 2026 8-K items 5.02, 7.01, 9.01 Officer or director change; Investor disclosure (Regulation FD) · Current report
Feb 17, 2026 10-K Annual report Dec 31, 2025
Feb 12, 2026 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Oct 31, 2025 SCHEDULE 13G/A Large holder update, amended
Oct 23, 2025 10-Q Quarterly report Sep 30, 2025
Oct 23, 2025 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Sep 11, 2025 8-K items 5.02, 9.01 Officer or director change · Current report
Aug 20, 2025 S-8 Employee stock plan registration
Jul 24, 2025 10-Q Quarterly report Jun 30, 2025
Jul 24, 2025 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Jul 21, 2025 8-K items 5.02, 9.01 Officer or director change · Current report
May 21, 2025 SD Conflict minerals report
May 12, 2025 8-K/A items 5.02, 9.01 Officer or director change · Current report, amended May 6, 2025
May 8, 2025 8-K items 5.07, 9.01 Shareholder vote · Current report May 6, 2025
Apr 24, 2025 SCHEDULE 13G/A Large holder update, amended
Apr 24, 2025 10-Q Quarterly report Mar 31, 2025
Apr 24, 2025 8-K items 5.02, 9.01 Officer or director change · Current report Apr 22, 2025
Apr 24, 2025 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Apr 14, 2025 8-K items 5.02, 9.01 Officer or director change · Current report Apr 9, 2025
Mar 21, 2025 ARS Annual report to shareholders Dec 31, 2024
40 of 245 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton WST · research, not advice